HopeStage
Back to all studies
RecruitingEUCTR 2017-001170-42

Safety and efficacy of NaBen (sodium benzoate)

About this title

Two-part Clinical Study to Evaluate the Safety and Efficacy of NaBen® in Adults with Refractory Schizophrenia

Read the official source — EUCTR 2017-001170-42

This historical record does not confirm current site availability.

Historical research recordPolandSchizophrenia
The study in practice

Understand this study

What is this study about?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Listed locations
Gdańsk and 3 more locationsSee all locations and recruitment
Study phase
Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This is historical registry information. What is the current study status and protocol?

Study clarity

Things to check before joining

Study start dateNot clearly listed
Recruitment status
Recruiting
Enrollment listed in the registry
287
Sponsor
SyneuRx International (Taiwan) Corp
Sponsor type
Other organization
Study type
Drug
Intervention type
Drug
Study phase
Phase 2, Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
Poland
Age range
Not clearly listed
Official registry ID
EUCTR 2017-001170-42
Official title
Show the full official title

An adaptive Phase II/III, Double-Blind, Randomized, Placebo-controlled, Two-Part, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen® (sodium benzoate), a D-Amino Acid Oxidase In...

Recruitment & locations

Currently recruiting

Gdańsk · Lublin · Wroclaw

Registry detailsOriginal registry record (opens in a new tab)
Current country statuses
  • Poland — Ongoing, recruiting
Historical country statuses

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is SyneuRx International (Taiwan) Corp.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies